Selinexor in Advanced Liposarcoma

Clinical trial NCT02606461 · COMPLETED

Trial details

NCT number: NCT02606461
Sponsor: Karyopharm Therapeutics Inc
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Dedifferentiated Liposarcoma

Start date: 2016-01-04
Primary completion: 2020-10-28
Enrollment: 342

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.